🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study Objective The project aims to implement an interdisciplinary therapeu...
Status
Completed
Location
University Playa Ancha
Start Date
2025-06-13
Trial ID
NCT07782255
Treatments Being Tested
Adults and adolescents will be asked to participate in a 10-week interventi...
Status
Completed
Location
Texas A&M University
Start Date
2023-01-01
Trial ID
NCT05725408
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
The MOMS Partnership aims to create "MOMS Zones" in New Haven neighborhoods...
Status
Terminated
Location
Boys & Girls Club of New Haven
Start Date
2015-04-22
Trial ID
NCT02459925
Treatments Being Tested
Given that up to 70% of people with secondary progressive MS are cognitivel...
Status
Completed
Location
Sunnybrook Health Science Center
Start Date
2019-03-18
Trial ID
NCT03679468
Treatments Being Tested
This study has two components. The first component is designed to assess an...
Status
Completed
Location
Yale Clinical and Community Research, 270 Congress Ave
Start Date
2017-12-11
Trial ID
NCT03293290
Treatments Being Tested
This is a single-blinded controlled cluster-randomized intervention trial r...
Status
Completed
Location
Flora Omsorgssenter
Start Date
2011-08
Trial ID
NCT01715506
Treatments Being Tested
Medication errors are common, life-threatening, costly but preventable. Inf...
Status
Completed
Location
TMU-Shuang-Ho Hospital
Start Date
2017-05-01
Trial ID
NCT03484793
Treatments Being Tested
Hyperacusis is the intolerance to sound levels that normally are judged acc...
Status
Completed
Location
Univ. of Maryland - Baltimore
Start Date
2002-07
Trial ID
NCT00890526
This trial evaluated the efficacy of an everolimus-based quadruple low immu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02-01
Trial ID
NCT01404325
Treatments Being Tested